These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 312044)

  • 1. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM; Parker LM
    Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple skeletal metastases of osteogenic sarcoma in a dog.
    Weller RE; Pool RR; Hornof WJ
    J Am Vet Med Assoc; 1979 Jul; 175(1):56-60. PubMed ID: 291598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation.
    Kirpensteijn J; Teske E; Kik M; Klenner T; Rutteman GR
    Anticancer Res; 2002; 22(5):2765-70. PubMed ID: 12529994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991).
    Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty MH; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 1993 Jan; 202(2):304-6. PubMed ID: 8428842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limb-sparing treatment for osteosarcoma in dogs.
    LaRue SM; Withrow SJ; Powers BE; Wrigley RH; Gillette EL; Schwarz PD; Straw RC; Richter SL
    J Am Vet Med Assoc; 1989 Dec; 195(12):1734-44. PubMed ID: 2599960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma--the winds of change.
    Mills EE
    S Afr Med J; 1978 May; 53(18):695-8. PubMed ID: 308700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of RA233 on metastasis in dogs with osteosarcomas.
    Hamilton HB; LaRue SM; Withrow SJ
    Am J Vet Res; 1987 Sep; 48(9):1380-2. PubMed ID: 3477971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
    Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
    Allen JC; Rosen G
    Ann Neurol; 1978 May; 3(5):441-4. PubMed ID: 310278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma.
    Delepine N; Delepine G; Cornille H; Brion F; Arnaud P; Desbois JC
    Anticancer Res; 1995; 15(2):489-94. PubMed ID: 7763028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New limb sparing therapy for osteosarcoma in the dog].
    Kirpensteijn J
    Tijdschr Diergeneeskd; 2005 Feb; 130(4):124. PubMed ID: 15754909
    [No Abstract]   [Full Text] [Related]  

  • 19. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
    Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
    Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative administration of high-dose methotrexate for osteosarcoma.
    Chan KW; Knowling MA; Duncan CP; Morton KS
    Can J Surg; 1984 May; 27(3):305-7, 309. PubMed ID: 6586272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.